| Type 2 Diabetes Mellitus |
1 |
1 |
| Plasma |
0 |
0.49 |
| Tolerance |
0 |
0.49 |
| Hyperglycemia |
0 |
0.39 |
| Metabolic Syndrome |
0 |
0.3 |
| Preventive Screening |
0 |
0.29 |
| Biliary Disease |
0 |
0.21 |
| Obesity |
0 |
0.21 |
| Metabolism |
0 |
0.2 |
| New York |
0 |
0.2 |
| Prediabetes |
0 |
0.2 |
| Non-Alcoholic Fatty Liver Disease |
0 |
0.16 |
| Weight Management |
0 |
0.16 |
| Cardiometabolic Risk Factors |
0 |
0.14 |
| Fatty Liver |
0 |
0.14 |
| Liver Disease |
0 |
0.14 |
| Obstructive Sleep Apnea |
0 |
0.14 |
| Sleep Apnea |
0 |
0.14 |
| Sleep Disorders |
0 |
0.14 |
| Biomarker |
0 |
0.1 |
| Clinical Guidelines |
0 |
0.1 |
| Colonoscopy |
0 |
0.1 |
| Diabetes Mellitus |
0 |
0.1 |
| Diabetes Research |
0 |
0.1 |
| Jobs |
0 |
0.1 |
| Liver |
0 |
0.1 |
| Mammogram |
0 |
0.1 |
| Maryland |
0 |
0.1 |
| Primary Care |
0 |
0.1 |
| Referral |
0 |
0.1 |
| Salary and Compensation |
0 |
0.1 |
| Sleep |
0 |
0.1 |
| Weight Gain |
0 |
0.1 |
| Weight Loss |
0 |
0.1 |
| Bowel Preparation |
0 |
0.08 |
| Breast Cancer |
0 |
0.08 |
| Cystic Fibrosis |
0 |
0.08 |
| Hypertension |
0 |
0.08 |
| Medical Life |
0 |
0.08 |
| Revenue and Practice Management |
0 |
0.08 |